In the inflammatory environment of the AD brain, inhibiting miR-4763-3p markedly enhances ATP11A expression, mediating inward flipping of phosphatidylserine (PS), thereby reducing neuronal apoptosis and alleviating extracellular inflammation. Here, ATP11A is linked to Alzheimer disease.